• Safety Study of (+)-α-Dihydrotetrabenazine for Patients with Moderate to Severe Tardive Dyskinesia

    Recruiting

    2 1 1
    Investigated diseases:
    Czechia Poland
  • Study on Nitrous Oxide and Oxygen for Treating Depression in Nursing Home Residents with Neurocognitive Disorders

    Recruiting

    2 1 1 1
    Investigated diseases:
    France
  • Study on the Safety and Tolerability of STK-002 for Patients with Autosomal Dominant Optic Atrophy

    Recruiting

    1 1 1
    Investigated diseases:
    Austria Denmark Germany Italy
  • Study on Lomustine and Temozolomide for Newly Diagnosed Glioblastoma Patients

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Denmark Norway Sweden
  • Study on the Effects of Rilvegostomig and Drug Combination for Patients with Advanced Gastric or Gastroesophageal Junction Cancer

    Recruiting

    2 1 1 1
    Spain
  • Study on Low-Dose Aldesleukin for Patients with Pemphigus, Mucous Membrane Pemphigoid, Polymyositis, Dermatomyositis, and Primary Sclerosing Cholangitis

    Recruiting

    2 1 1
    Investigated drugs:
    Germany
  • Study on Glioblastoma Treatment with Olaptesed Pegol and Radiation, with Bevacizumab or Pembrolizumab, for Patients with Unmethylated MGMT Promoter

    Recruiting

    1 1 1 1
    Investigated diseases:
    Germany
  • Study on the Safety and Effectiveness of Baricitinib for Children Aged 1 to 17 with Juvenile Idiopathic Arthritis

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Belgium Czechia Denmark France Germany +3
  • Study on the Safety and Effectiveness of Lufepirsen Gel for Patients with Persistent Corneal Epithelial Defects

    Recruiting

    2 1
    Investigated diseases:
    Investigated drugs:
    Germany Italy Spain
  • Study of Ixekizumab Treatment Effects on Joint and Bone Inflammation in Patients with Axial Spondyloarthritis and Psoriatic Arthritis Using Advanced Imaging Methods

    Recruiting

    3 1 1 1
    Investigated drugs:
    Denmark

powered by